Monthly Reports

Each month we publish a snapshot of how the US clinical trial recruiting pipeline is changing — which drugs are gaining ground, which are slipping, which are entering for the first time, and which have exited recruiting entirely. Built from monthly captures of the public ClinicalTrials.gov registry.